UBS Group’s Autonomix Medical AMIX Stock Holding History

UBS Group’s Portfolio AMIX Stock Details AMIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.1K	Buy	1,595 +1,589	+26,483%	+$14.3K	﹤0.01%	8229
2025 Q4	$70	Buy	6 +2	+50%	+$39	﹤0.01%	10234
2025 Q3	$85	Sell	4 -208	-98%	-$5.44K	﹤0.01%	9948
2025 Q2	$7K	Sell	212 -547	-72%	-$19.6K	﹤0.01%	9045
2025 Q1	$27.9K	Sell	759 -1,169	-61%	-$64.6K	﹤0.01%	7997
2024 Q4	$152K	Buy	1,928 +1,894	+5,571%	+$335K	﹤0.01%	6620
2024 Q3	$8.52K	Sell	34 -3	-8%	-$1.01K	﹤0.01%	7835
2024 Q2	$14.8K	Buy	+37	New	+$36.6K	﹤0.01%	7497

Other funds holding AMIX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

UBS Group's AMIX Position: Q1 2026 in Review

UBS Group increased its Autonomix Medical (AMIX) stake by 26,483% in Q1 2026, buying an estimated $14.3K and bringing the position to 1,595 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #8229.

UBS Group first reported a position in AMIX in Q2 2024 and has held it in 8 quarters since. The position peaked at $152K in Q4 2024. 10 funds tracked by Wall St. Rank hold AMIX as of Q1 2026.

UBS Group held 1,595 shares of Autonomix Medical worth $13.1K as of Q1 2026.
UBS Group bought 1,589 Autonomix Medical shares in Q1 2026, an estimated $14.3K.
Autonomix Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8229 holding.
UBS Group first reported a position in Autonomix Medical in Q2 2024 and has held it in 8 quarters since.
UBS Group's Autonomix Medical position peaked at $152K in Q4 2024.
10 funds tracked by Wall St. Rank held Autonomix Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.